The contract with the nonprofit generic pharmaceutical manufacturer Civica would make insulin the first generic drug produced and sold under California’s own label next year.
The contract with the nonprofit generic pharmaceutical manufacturer Civica would make insulin the first generic drug produced and sold under California’s own label next year.